<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8</volume><submitter>Bichon A</submitter><pubmed_abstract>&lt;b>Background:&lt;/b> Adult hemophagocytic lymphohistiocytosis (HLH) is highly lethal in the ICU. The diagnostic and therapeutic emergency that HLH represents is compounded by its unknown pathophysiological mechanisms. Here, we report on a large cohort of adult HLH in the ICU (ICU-HLH). We analyzed prognostic factors associated with mortality to define the diagnostic and therapeutic challenges in this specific population. &lt;b>Methods:&lt;/b> This retrospective study included adult patients diagnosed with HLH in four ICUs in Marseille, France between 2010 and 2020. Patients who fulfilled the HLH-2004 criteria (≥ 4/8) and/or had an HScore ≥ 169 were diagnosed with HLH. HLH was categorized into four groups according to etiology: sepsis-associated HLH, intracellular infection-associated HLH, malignan</pubmed_abstract><journal>Frontiers in medicine</journal><pagination>735796</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8526960</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>High Mortality of HLH in ICU Regardless Etiology or Treatment.</pubmed_title><pmcid>PMC8526960</pmcid><pubmed_authors>Bourenne J</pubmed_authors><pubmed_authors>Bichon A</pubmed_authors><pubmed_authors>Kaplanski G</pubmed_authors><pubmed_authors>Gainnier M</pubmed_authors><pubmed_authors>Hraiech S</pubmed_authors><pubmed_authors>Carvelli J</pubmed_authors><pubmed_authors>Guervilly C</pubmed_authors><pubmed_authors>Pauly V</pubmed_authors><pubmed_authors>Allardet-Servent J</pubmed_authors><pubmed_authors>Papazian L</pubmed_authors><pubmed_authors>Mokart D</pubmed_authors></additional><is_claimable>false</is_claimable><name>High Mortality of HLH in ICU Regardless Etiology or Treatment.</name><description>&lt;b>Background:&lt;/b> Adult hemophagocytic lymphohistiocytosis (HLH) is highly lethal in the ICU. The diagnostic and therapeutic emergency that HLH represents is compounded by its unknown pathophysiological mechanisms. Here, we report on a large cohort of adult HLH in the ICU (ICU-HLH). We analyzed prognostic factors associated with mortality to define the diagnostic and therapeutic challenges in this specific population. &lt;b>Methods:&lt;/b> This retrospective study included adult patients diagnosed with HLH in four ICUs in Marseille, France between 2010 and 2020. Patients who fulfilled the HLH-2004 criteria (≥ 4/8) and/or had an HScore ≥ 169 were diagnosed with HLH. HLH was categorized into four groups according to etiology: sepsis-associated HLH, intracellular infection-associated HLH, malignan</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2026-07-16T15:59:09.683Z</modification><creation>2025-04-04T19:44:36.048Z</creation></dates><accession>S-EPMC8526960</accession><cross_references><pubmed>34692727</pubmed><doi>10.3389/fmed.2021.735796</doi></cross_references></HashMap>